Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Advani

Showing results (21-30 of 99) with videos related to

Pageof 10
Sort By:
BMJ Open Diabetes Research & Care|October 2, 2020
Experiences and perspectives of the parents of emerging adults living with type 1 diabetesCheryl Pritlove, Benjamin Markowitz, Geetha Mukerji, et al.
Endocrinology|February 28, 2020
The Endothelial Barrier Is not Rate-limiting to Insulin Action in the Myocardium of Male MiceRajiv Sanwal, Negar Khosraviani, Suzanne L Advani, et al.
JAMA Network Open|July 13, 2019
The 3i Conceptual Framework for Recognizing Patient Perspectives of Type 1 Diabetes During Emerging AdulthoodBenjamin Markowitz, Cheryl Pritlove, Geetha Mukerji, et al.
BMJ Open|August 29, 2024
Patient, family and caregiver engagement in diabetes care: a scoping review protocolDita Chamoun, Mathankki Ramasamy, Carolyn Ziegler, et al.
International Journal of Molecular Sciences|August 16, 2020
The Dipeptidyl Peptidase-4 Inhibitor Linagliptin Directly Enhances the Contractile Recovery of Mouse Hearts at a Concentration Equivalent to that Achieved with Standard Dosing in HumansSri Nagarjun Batchu, Veera Ganesh Yerra, Youan Liu, et al.
Nephrology (Carlton, Vic.)|February 24, 2011
Inhibition of the epidermal growth factor receptor preserves podocytes and attenuates albuminuria in experimental diabetic nephropathyAndrew Advani, Kathryn J Wiggins, Alison J Cox, et al.
Diabetes|March 29, 2014
Diabetes induces lysine acetylation of intermediary metabolism enzymes in the kidneyHari Kosanam, Kerri Thai, Yanling Zhang, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|January 23, 2008
The investigation and management of severe hyperandrogenism pre- and postmenopause: non-tumor disease is strongly associated with metabolic syndrome and typically responds to insulin-sensitization with metforminSuresh Vaikkakara, Ebaa Al-Ozairi, Eelin Lim, et al.
Cardiovascular Therapeutics|September 12, 2012
DPP-4 inhibition attenuates cardiac dysfunction and adverse remodeling following myocardial infarction in rats with experimental diabetesKim Alexander Connelly, Yanling Zhang, Andrew Advani, et al.
Biomed Research International|September 25, 2013
Role of the eNOS-NO system in regulating the antiproteinuric effects of VEGF receptor 2 inhibition in diabetesAndrew Advani, Kim A Connelly, Suzanne L Advani, et al.
Pageof 10

Showing results (21-30 of 99) with videos related to

Sort By:
Pageof 10
BMJ Open Diabetes Research & Care|October 2, 2020
Experiences and perspectives of the parents of emerging adults living with type 1 diabetesCheryl Pritlove, Benjamin Markowitz, Geetha Mukerji, et al.
Endocrinology|February 28, 2020
The Endothelial Barrier Is not Rate-limiting to Insulin Action in the Myocardium of Male MiceRajiv Sanwal, Negar Khosraviani, Suzanne L Advani, et al.
JAMA Network Open|July 13, 2019
The 3i Conceptual Framework for Recognizing Patient Perspectives of Type 1 Diabetes During Emerging AdulthoodBenjamin Markowitz, Cheryl Pritlove, Geetha Mukerji, et al.
BMJ Open|August 29, 2024
Patient, family and caregiver engagement in diabetes care: a scoping review protocolDita Chamoun, Mathankki Ramasamy, Carolyn Ziegler, et al.
International Journal of Molecular Sciences|August 16, 2020
The Dipeptidyl Peptidase-4 Inhibitor Linagliptin Directly Enhances the Contractile Recovery of Mouse Hearts at a Concentration Equivalent to that Achieved with Standard Dosing in HumansSri Nagarjun Batchu, Veera Ganesh Yerra, Youan Liu, et al.
Nephrology (Carlton, Vic.)|February 24, 2011
Inhibition of the epidermal growth factor receptor preserves podocytes and attenuates albuminuria in experimental diabetic nephropathyAndrew Advani, Kathryn J Wiggins, Alison J Cox, et al.
Diabetes|March 29, 2014
Diabetes induces lysine acetylation of intermediary metabolism enzymes in the kidneyHari Kosanam, Kerri Thai, Yanling Zhang, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|January 23, 2008
The investigation and management of severe hyperandrogenism pre- and postmenopause: non-tumor disease is strongly associated with metabolic syndrome and typically responds to insulin-sensitization with metforminSuresh Vaikkakara, Ebaa Al-Ozairi, Eelin Lim, et al.
Cardiovascular Therapeutics|September 12, 2012
DPP-4 inhibition attenuates cardiac dysfunction and adverse remodeling following myocardial infarction in rats with experimental diabetesKim Alexander Connelly, Yanling Zhang, Andrew Advani, et al.
Biomed Research International|September 25, 2013
Role of the eNOS-NO system in regulating the antiproteinuric effects of VEGF receptor 2 inhibition in diabetesAndrew Advani, Kim A Connelly, Suzanne L Advani, et al.
Pageof 10